Evaluation of Online Tool (E-TOOL SCS) in Spinal Cord Stimulaion
Launched by ISTITUTI CLINICI SCIENTIFICI MAUGERI SPA · Jan 25, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Spinal Cord Stimulation (SCS) has been a therapy in the treatment of chronic pain for 50 years, particularly for patients resistant to conventional pharmacological treatment and other less complex invasive procedures. Over the years, various versions of guidelines have been established and drafted for the selection and clinical indications in which SCS therapy is most likely to be successful. The main clinical indications include:
* Chronic pain in the lumbar region and lower limbs, especially in patients who have undergone spine surgeries (Failed Back Surgery Syndrome, FBSS).
* Complex Re...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Males and females aged between 18 and 85 years.
- • Patients with chronic pain and indication for implantation of a temporary neurostimulator for spinal cord stimulation testing.
- • Signed informed consent.
- Exclusion Criteria:
- • • Patients who, in the researcher's judgment, are unable to follow the protocol instructions.
- • Patients in presumed/confirmed pregnancy.
- • Contraindications to implantation.
About Istituti Clinici Scientifici Maugeri Spa
Istituti Clinici Scientifici Maugeri S.p.A. is a prestigious Italian healthcare organization dedicated to advancing medical research and clinical practice. With a strong focus on patient-centered care, the institution integrates innovative clinical trials into its comprehensive services, fostering collaboration between researchers and healthcare professionals. Known for its commitment to high-quality standards and ethical practices, Istituti Clinici Scientifici Maugeri S.p.A. plays a pivotal role in the development of new therapies and treatment modalities, contributing significantly to the global medical community and enhancing patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pavia, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported